Cargando…

COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea

(1) Background: The vaccine supply is likely to be limited in 2021 due to constraints in manufacturing. To maximize the benefit from the rollout phase, an optimal strategy of vaccine allocation is necessary based on each country’s epidemic status. (2) Methods: We first developed a heterogeneous popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Youngsuk, Lee, Jacob, Kim, Yeonju, Kwon, Donghyok, Jung, Eunok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296292/
https://www.ncbi.nlm.nih.gov/pubmed/34203821
http://dx.doi.org/10.3390/ijerph18126469
_version_ 1783725605300207616
author Ko, Youngsuk
Lee, Jacob
Kim, Yeonju
Kwon, Donghyok
Jung, Eunok
author_facet Ko, Youngsuk
Lee, Jacob
Kim, Yeonju
Kwon, Donghyok
Jung, Eunok
author_sort Ko, Youngsuk
collection PubMed
description (1) Background: The vaccine supply is likely to be limited in 2021 due to constraints in manufacturing. To maximize the benefit from the rollout phase, an optimal strategy of vaccine allocation is necessary based on each country’s epidemic status. (2) Methods: We first developed a heterogeneous population model considering the transmission matrix using maximum likelihood estimation based on the epidemiological records of individual COVID-19 cases in the Republic of Korea. Using this model, the vaccine priorities for minimizing mortality or incidence were investigated. (3) Results: The simulation results showed that the optimal vaccine allocation strategy to minimize the mortality (or incidence) was to prioritize elderly and healthcare workers (or adults) as long as the reproductive number was below [Formula: see text] (or over [Formula: see text]). (4) Conclusion: Our simulation results support the current Korean government vaccination priority strategy, which prioritizes healthcare workers and senior groups to minimize mortality, under the condition that the reproductive number remains below [Formula: see text]. This study revealed that, in order to maintain the current vaccine priority policy, it is important to ensure that the reproductive number does not exceed the threshold by concurrently implementing nonpharmaceutical interventions.
format Online
Article
Text
id pubmed-8296292
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82962922021-07-23 COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea Ko, Youngsuk Lee, Jacob Kim, Yeonju Kwon, Donghyok Jung, Eunok Int J Environ Res Public Health Article (1) Background: The vaccine supply is likely to be limited in 2021 due to constraints in manufacturing. To maximize the benefit from the rollout phase, an optimal strategy of vaccine allocation is necessary based on each country’s epidemic status. (2) Methods: We first developed a heterogeneous population model considering the transmission matrix using maximum likelihood estimation based on the epidemiological records of individual COVID-19 cases in the Republic of Korea. Using this model, the vaccine priorities for minimizing mortality or incidence were investigated. (3) Results: The simulation results showed that the optimal vaccine allocation strategy to minimize the mortality (or incidence) was to prioritize elderly and healthcare workers (or adults) as long as the reproductive number was below [Formula: see text] (or over [Formula: see text]). (4) Conclusion: Our simulation results support the current Korean government vaccination priority strategy, which prioritizes healthcare workers and senior groups to minimize mortality, under the condition that the reproductive number remains below [Formula: see text]. This study revealed that, in order to maintain the current vaccine priority policy, it is important to ensure that the reproductive number does not exceed the threshold by concurrently implementing nonpharmaceutical interventions. MDPI 2021-06-15 /pmc/articles/PMC8296292/ /pubmed/34203821 http://dx.doi.org/10.3390/ijerph18126469 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ko, Youngsuk
Lee, Jacob
Kim, Yeonju
Kwon, Donghyok
Jung, Eunok
COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea
title COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea
title_full COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea
title_fullStr COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea
title_full_unstemmed COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea
title_short COVID-19 Vaccine Priority Strategy Using a Heterogenous Transmission Model Based on Maximum Likelihood Estimation in the Republic of Korea
title_sort covid-19 vaccine priority strategy using a heterogenous transmission model based on maximum likelihood estimation in the republic of korea
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296292/
https://www.ncbi.nlm.nih.gov/pubmed/34203821
http://dx.doi.org/10.3390/ijerph18126469
work_keys_str_mv AT koyoungsuk covid19vaccineprioritystrategyusingaheterogenoustransmissionmodelbasedonmaximumlikelihoodestimationintherepublicofkorea
AT leejacob covid19vaccineprioritystrategyusingaheterogenoustransmissionmodelbasedonmaximumlikelihoodestimationintherepublicofkorea
AT kimyeonju covid19vaccineprioritystrategyusingaheterogenoustransmissionmodelbasedonmaximumlikelihoodestimationintherepublicofkorea
AT kwondonghyok covid19vaccineprioritystrategyusingaheterogenoustransmissionmodelbasedonmaximumlikelihoodestimationintherepublicofkorea
AT jungeunok covid19vaccineprioritystrategyusingaheterogenoustransmissionmodelbasedonmaximumlikelihoodestimationintherepublicofkorea